DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Varian to deliver six technical presentations at ICCR

Shandong Cancer Hospital proton center joins FlashForward Consortium for flash proton therapy research

Varian Medical Systems presents latest innovations in radiotherapy at DEGRO 25

Merit Medical awarded interventional fluid management agreement with Premier

RaySearch to exhibit the latest news for particle therapy at PTCOG 58

Varian announces acquisitions of Endocare and Alicon

Flash irradiation delivered in a IBA ProteusONE proton therapy treatment room

Herlev University Hospital treats first patient in Denmark on Varian Halcyon system

Varian-equipped New York Proton Therapy Center opens with ribbon cutting event

Varian to host FlashForward Consortium meeting at PTCOG58

BC Cancer researchers demonstrate the promise of a novel radiation treatment for metastatic cancer patients

Press releases may be edited for formatting or style
VANCOUVER, B.C. – A new study co-led by BC Cancer researchers has found that the use of Stereotactic Ablative Radiotherapy (SABR) technology may improve survival rates for patients with limited metastatic cancer.
​These findings are the result of the world’s first randomized clinical trial of SABR as it relates to cancer that has already spread to other parts of the body.

The study, led at BC Cancer by Dr. Robert Olson, along with an international team of researchers was recently published in The Lancet. SABR technology is a highly precise form of radiotherapy where much higher doses of radiation can be safely delivered to tumours over a shorter time period. The technology features advanced machines with built in CT scans that can sculpt the dose of radiation to tumours from multiple angles while reducing the dose to healthy normal nearby tissue. This both increases cure rates, while reducing the risk of side effects.
Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.




“What excites me most about this study is the potential survival benefit from Stereotactic Ablative Radiotherapy. These results confirm the need for a larger Phase III trial,” says Dr. Robert Olson, radiation oncologist, BC Cancer – Prince George.

It has recently been hypothesized that patients with a small number of additional tumours could be cured of the disease once all growths are killed with radiation, but there was not a lot of evidence to support the claim until now. The SABR-COMET trial aimed to assess the effect of SABR on survival, outcomes, toxicity and quality of life in patients with a controlled primary tumour, and one to five additional tumours.

During the randomized trial, which took place over four years at ten centres worldwide (including all six BC Cancer centres), the patient group who was treated with SABR technology saw an overall improvement in survival. However, there is a possibility of serious side effects, so future research is needed to confirm its efficacy.

Phase III trials are needed to conclusively show an overall survival benefit and to determine the number of metastatic tumours that could benefit from SABR treatment. “A Phase III trial could be paradigm-changing. It could support using ablative therapies in the setting of metastatic disease, to increase survival rates in some patients,” says Dr. Olson.

The study was funded by the Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant, with the BC Cancer Foundation launching a fundraising campaign to support the research led by Dr. Olson in Prince George at the end of 2018.
  Pages: 1 - 2 >>

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

E-Mail-Werbung
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich auf DOTmed bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Servicetechniker
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED